Insulin products covered under Medicare Part D now have a $35 cost-sharing cap for a month’s supply. This includes any new insulin products that become available during the plan year. The cost-sharing cap also applies to insulin delivered through a pump that is covered under the durable medical equipment benefit under both Medicare Part B and Medicare Advantage. Not sure how that affects you? Check out CMS’s FAQ for more.
NCPA
